Tag: orthobiologics market report

  • 2024 Orthobiologics Market Analysis: Market Size, Key Drivers, and Segment Insights

    2024 Orthobiologics Market Analysis: Market Size, Key Drivers, and Segment Insights

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What is the Expected Growth Rate of the Orthobiologics Market from 2024 to 2033?
    The orthobiologics market size has shown strong growth recently. It is anticipated to rise from $6.65 billion in 2023 to $7.08 billion in 2024, at a CAGR of 6.4%. Factors contributing to this growth include the rise in orthopedic diseases, a shift toward minimally invasive procedures, an increase in reconstructive surgeries, higher healthcare expenditure, and greater awareness among patients and providers.

    The orthobiologics market is projected to grow to $9.12 billion by 2028 at a CAGR of 6.5%. Growth factors include an aging population, development of advanced products, and favorable reimbursement policies. Key trends involve advancements in regenerative medicine and product innovations.

    Claim Your Free Sample of the Global Orthobiologics Market Report Today!
    https://www.thebusinessresearchcompany.com/sample.aspx?id=16139&type=smp

    What Key Factors Are Fueling the Growth of the Orthobiologics Market?
    The rising incidence of road accidents and sports injuries is expected to promote the orthobiologics market’s growth. These incidents often affect the musculoskeletal system and are influenced by various factors. Orthobiologics aid in healing by promoting tissue repair and reducing inflammation. The National Highway Traffic Safety Administration reported a 10.5% increase in motor vehicle fatalities in 2021. Thus, the rising number of injuries is driving the orthobiologics market.

    What Are the Major Segments of the Orthobiologics Market?
    1) By Product Type: Viscosupplements, Bone Growth Factors, Demineralized Bone Matrix, Synthetic Bone Substitutes, Cellular Allograft, Other Products
    2) By Application: Spinal Fusion, Maxillofacial And Dental, Soft Tissue Repair, Reconstructive And Fracture Surgery, Other Applications
    3) By End User: Hospitals, Orthopedic Clinics, Ambulatory Surgery Centers, Other End Users

    What New Trends Are Transforming the Orthobiologics Market?
    Major companies in the orthobiologics market are creating advanced solutions, like dry allograft mixtures, to improve bone healing in orthopedic procedures. Dry allograft mixtures combine robust cortical fibers with mineralized bone for enhanced support. For example, in May 2024, Isto Biologics launched Fibrant Liberty allograft, which is customizable for various surgical needs.

    Order Now for Fast Delivery of Your Orthobiologics Market Report!
    https://www.thebusinessresearchcompany.com/report/orthobiologics-global-market-report

    Which Regions Are Driving Growth in the Orthobiologics Market?
    North America was the largest region in the orthobiologics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the orthobiologics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    The Orthobiologics Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the orthobiologics market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Orthobiologics Market Include

    1. Orthobiologics Market Executive Summary
    2. Orthobiologics Market Segments
    3. Orthobiologics Market Size And Template Market Growth Rate
    4.  Key Orthobiologics Market Trends
    5. Major Orthobiologics Market Drivers
    ……
    25. Key Mergers And Acquisitions In The Orthobiologics Market
    26. Top Orthobiologics Companies
    27. Orthobiologics Market Opportunities And Strategies
    28. Orthobiologics Market, Conclusions And Recommendations
    29. Appendix

    Discover Related Reports by The Business Research Company:
    Oral Biologics & Biosimilars Global Market Report 2024
    https://www.thebusinessresearchcompany.com/report/oral-biologics-and-biosimilars-global-market-report

    Biologics Contract Development Global Market Report 2024
    https://www.thebusinessresearchcompany.com/report/biologics-contract-development-global-market-report

    Biologics Testing Global Market Report 2024
    https://www.thebusinessresearchcompany.com/report/biologics-testing-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:
    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Overview Of The Orthobiologics Market 2024-2033: Growth And Major Players Analysis

    Overview Of The Orthobiologics Market 2024-2033: Growth And Major Players Analysis

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    Market Growth Overview

    • Current Market Size: The orthobiologics market was valued at $6.65 billion in 2023.
    • Short-Term Growth: Expected to rise to $7.08 billion in 2024, with a CAGR of 6.4%.
    • Long-Term Growth: Projected to reach $9.12 billion by 2028, growing at a CAGR of 6.5%.

    Factors Driving Growth

    • Historical Growth Drivers:
      • Increase in orthopedic diseases and conditions.
      • Shift towards minimally invasive procedures.
      • Rise in reconstructive surgeries.
      • Growing healthcare expenditure.
      • Enhanced awareness among patients and providers.
      • Economic development in emerging markets.
    • Future Growth Drivers:
      • Aging population and sedentary lifestyles.
      • Continuous advancement in orthobiologic products.
      • Favorable reimbursement policies.
      • New regulatory approvals.
      • Expanded indications for existing products.

    View More On The Orthobiologics Market Report 2024 – https://www.thebusinessresearchcompany.com/report/orthobiologics-global-market-report

    Trends Influencing the Market

    • Regenerative Medicine: Advances in regenerative medicine are driving innovation.
    • Product Innovations: New and improved products are emerging.
    • Technological Advancements: Cutting-edge technologies are being developed.
    • Strategic Initiatives: Companies are engaging in strategic moves to capture market share.
    • Market Expansion: Growing markets in various regions are contributing to overall growth.

    Impact of Sports Injuries and Road Accidents

    • Growth from Injuries:
      • Increased number of road accidents and sports injuries.
      • High incidence of musculoskeletal damage from these events.
    • Treatment Benefits:
      • Orthobiologics aid in faster healing and reducing inflammation.
      • Utilization of bone grafts, growth factors, stem cells, and platelet-rich plasma.
    • Statistics:
      • In 2021, US motor vehicle crash fatalities increased by 10.5%, totaling approximately 42,915 deaths.

    Innovative Developments

    • Dry Allograft Mixtures:
      • New solutions like dry allograft mixtures are enhancing bone healing.
      • Example: Fibrant Liberty allograft by Isto Biologics features robust cortical fibers that support new bone formation and prevent graft migration.

    Recent Major Acquisitions

    • Zimmer Biomet and Embody:
      • In February 2023, Zimmer Biomet acquired Embody Inc. for $155 million.
      • This acquisition supports Zimmer Biomet’s commitment to innovation in sports medicine with collagen-based biologic products.

    Market Segmentation

    • By Product Type:
      • Viscosupplements, Bone Growth Factors, Demineralized Bone Matrix, Synthetic Bone Substitutes, Cellular Allograft, Other Products.
    • By Application:
      • Spinal Fusion, Maxillofacial and Dental, Soft Tissue Repair, Reconstructive and Fracture Surgery, Other Applications.
    • By End User:
      • Hospitals, Orthopedic Clinics, Ambulatory Surgery Centers, Other End Users.

    Regional Insights

    • North America: Dominated the orthobiologics market in 2023.
    • Asia-Pacific: Expected to be the fastest-growing region in the forecast period.

    In summary, the orthobiologics market is on a strong upward trajectory, driven by advances in medical technology, increasing prevalence of injuries, and expanding market opportunities. The sector is poised for substantial growth, with innovative developments and strategic acquisitions shaping its future.

    Request A Sample Of The Global Orthobiologics Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=16139&type=smp